Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lee

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
JMIR Research Protocols|July 8, 2025
Correction: Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children With Neurogenetic Conditions (Project WellCAST): Protocol for a Randomized Controlled TrialBridgette Kelleher, Kaleb Emerson, Lyndsey N Graham, et al.
Global Change Biology|December 17, 2019
Identifying potentially invasive non-native marine and brackish water species for the Arabian Gulf and Sea of OmanStacey A Clarke, Lorenzo Vilizzi, Laura Lee, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 11, 2007
Structure of the hypothetical protein PF0899 from Pyrococcus furiosus at 1.85 A resolutionLaura-Lee Clancy Kelley, Bret D Dillard, Wolfram Tempel, et al.
Nature Communications|May 20, 2020
Translational control of breast cancer plasticityMichael Jewer, Laura Lee, Matthew Leibovitch, et al.
Vaccine|November 8, 2020
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United StatesMonica Schoch-Spana, Emily K Brunson, Rex Long, et al.
Journal of Oncology Practice|March 5, 2019
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical TrialsJeanne M Regnante, Nicole A Richie, Lola Fashoyin-Aje, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
The Lancet Regional Health. Europe|April 18, 2025
Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmissionGina E C Charnley, Tilly Alcayna, Alex Almuedo-Riera, et al.
JNCI Cancer Spectrum|August 12, 2025
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataAdam M Brufsky, Kent F Hoskins, Henry J Conter, et al.
JAMA|February 8, 2018
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO ExtensionMelanie Calvert, Derek Kyte, Rebecca Mercieca-Bebber, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
JMIR Research Protocols|July 8, 2025
Correction: Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers of Children With Neurogenetic Conditions (Project WellCAST): Protocol for a Randomized Controlled TrialBridgette Kelleher, Kaleb Emerson, Lyndsey N Graham, et al.
Global Change Biology|December 17, 2019
Identifying potentially invasive non-native marine and brackish water species for the Arabian Gulf and Sea of OmanStacey A Clarke, Lorenzo Vilizzi, Laura Lee, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 11, 2007
Structure of the hypothetical protein PF0899 from Pyrococcus furiosus at 1.85 A resolutionLaura-Lee Clancy Kelley, Bret D Dillard, Wolfram Tempel, et al.
Nature Communications|May 20, 2020
Translational control of breast cancer plasticityMichael Jewer, Laura Lee, Matthew Leibovitch, et al.
Vaccine|November 8, 2020
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United StatesMonica Schoch-Spana, Emily K Brunson, Rex Long, et al.
Journal of Oncology Practice|March 5, 2019
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical TrialsJeanne M Regnante, Nicole A Richie, Lola Fashoyin-Aje, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
The Lancet Regional Health. Europe|April 18, 2025
Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmissionGina E C Charnley, Tilly Alcayna, Alex Almuedo-Riera, et al.
JNCI Cancer Spectrum|August 12, 2025
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataAdam M Brufsky, Kent F Hoskins, Henry J Conter, et al.
JAMA|February 8, 2018
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO ExtensionMelanie Calvert, Derek Kyte, Rebecca Mercieca-Bebber, et al.
Pageof 30